Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
21.60
+0.30 (1.41%)
At close: Mar 13, 2026
Market Cap957.84M -10.7%
Revenue (ttm)452.29M +5.3%
Net Income74.76M +19.1%
EPS1.69 +19.1%
Shares Out44.34M
PE Ratio12.81
Forward PEn/a
Dividend1.50 (6.94%)
Ex-Dividend Daten/a
Volume10,373
Average Volume18,656
Open22.20
Previous Close21.30
Day's Range21.00 - 22.20
52-Week Range19.40 - 27.30
Beta0.64
RSI52.57
Earnings DateApr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2025, Vistin Pharma ASA's revenue was 452.29 million, an increase of 5.31% compared to the previous year's 429.50 million. Earnings were 74.76 million, an increase of 19.13%.

Financial Statements